Merit Medical Systems Inc (MMSI)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Merit Medical Systems Inc (MMSI)
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.
Key Insights
Critical company metrics and information
Share Price
$102.09Market Cap
$5.95 BillionTotal Outstanding Shares
58.28 Million SharesTotal Employees
6,950Dividend
No dividendIPO Date
February 26, 1992SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.merit.com
Historical Stock Splits
If you bought 1 share of MMSI before August 15, 2003, you'd have 2.22 shares today.
Execution Date | Split Amount |
---|---|
May 6, 2011 | 5-for-4 |
December 3, 2003 | 4-for-3 |
August 15, 2003 | 4-for-3 |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities | $410.37 Million |
Net Cash Flow From Operating Activities | $214.31 Million |
Net Cash Flow, Continuing | $462.13 Million |
Net Cash Flow From Investing Activities, Continuing | $-162.55 Million |
Net Cash Flow | $462.13 Million |
Net Cash Flow From Financing Activities, Continuing | $410.37 Million |
Net Cash Flow From Operating Activities, Continuing | $214.31 Million |
Net Cash Flow From Investing Activities | $-162.55 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income/Loss From Continuing Operations Before Tax | $148.31 Million |
Diluted Average Shares | $118.20 Million |
Income/Loss From Continuing Operations After Tax | $120.04 Million |
Gross Profit | $620.88 Million |
Net Income/Loss | $120.04 Million |
Provision For Loan, Lease, And Other Losses | $1.27 Million |
Net Income/Loss Attributable To Parent | $120.04 Million |
Revenues | $1.33 Billion |
Income Tax Expense/Benefit | $28.28 Million |
Other Operating Expenses | $83.73 Million |
Benefits Costs and Expenses | $1.18 Billion |
Basic Average Shares | $116.35 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Net Income/Loss Available To Common Stockholders, Basic | $120.04 Million |
Costs And Expenses | $1.18 Billion |
Cost Of Revenue | $704.99 Million |
Selling, General, and Administrative Expenses | $384.41 Million |
Nonoperating Income/Loss | $-4.43 Million |
Operating Income/Loss | $152.74 Million |
Basic Earnings Per Share | $2.07 |
Operating Expenses | $468.14 Million |
Diluted Earnings Per Share | $2.05 |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Equity | $1.32 Billion |
Noncurrent Assets | $1.30 Billion |
Other Non-current Assets | $910.11 Million |
Noncurrent Liabilities | $853.60 Million |
Liabilities | $1.05 Billion |
Current Assets | $1.08 Billion |
Long-term Debt | $750.50 Million |
Assets | $2.38 Billion |
Current Liabilities | $201.08 Million |
Liabilities And Equity | $2.38 Billion |
Other Non-current Liabilities | $103.09 Million |
Other Current Assets | $767.79 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Equity Attributable To Parent | $1.32 Billion |
Fixed Assets | $389.65 Million |
Inventory | $310.53 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Related Companies
View additional S&P 500 companies similar to Merit Medical Systems Inc (MMSI)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.